Evolent Health (EVH) announced an agreement to expand its Technology and Services solution for oncology with its existing partner, Centene (CNC). Centene will expand its use of Evolent Health’s oncology solution across its Centene and WellCare Medicare Advantage members nationally. This agreement deepens the specialty care partnership between Centene and Evolent in the MA market.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EVH:
